-
Description
-
Shipping
-
Review
Research-grade Ipamorelin / CJC-1295 Blend 10 mg as a lyophilized powder in a glass vial. This blend contains 5 mg of Ipamorelinand 5 mg of CJC-1295 without DAC (Mod GRF 1-29), combined for synergistic research into growth hormone secretion.
| Parameter | Value |
|---|---|
| Form | Lyophilized peptide powder |
| Content | 5 mg Ipamorelin & 5 mg CJC-1295 (no DAC) per vial |
| Packaging | Glass vial with sterile closure |
| Storage | Store lyophilized at 2–8 °C (desiccated, protect from light) |
| Molecular formula | Mixture |
| Molecular weight | Mixture |
| Sequences |
Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2 CJC-1295 (no DAC): Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| CAS number |
170851-70-4 (Ipamorelin) 863288-34-0 (CJC-1295 no DAC) |
What is the Ipamorelin / CJC-1295 Blend?
This research blend combines two growth hormone (GH) secretagogues that act on different receptors. Ipamorelin is a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R). CJC-1295 (no DAC), also known as Modified GRF (1-29), is an analog of Growth Hormone Releasing Hormone (GHRH). They are combined to study the synergistic effect of activating both pathways simultaneously.
In laboratory studies, this blend is associated with research into:
- synergistic release of growth hormone (GH)
- simultaneous agonism of GHS-R and GHRH receptors
- pituitary function and endocrine signaling
- pulsatile GH secretion models
Slovakia - delivery usually within 3 to 7 business days.
Czech Republic - delivery usually within 3 to 7 business days.
Hungary - delivery usually within 3 to 7 business days.
International delivery takes 4 to 30 days depending on the country.
As soon as we ship your package, we'll automatically send you an email with a tracking link.
- 14-day money-back guarantee
- Fast worldwide delivery
- Third-party tested





